Achievements and perspectives in gastroenterology;ERFOLGE UND PERSPEKTIVEN IN DER GASTROENTEROLOGIE

Internist

Volumn 39, Issue 4, 1998, Pages 373-380

  Folsch U R ^a   Manns, M P ^b   Riemann, J F ^c  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACHIEVEMENT; ARTICLE; COLORECTAL CARCINOMA; CYSTIC FIBROSIS; GASTROENTEROLOGY; GENETICS; GERMANY; HELICOBACTER PYLORI; HUMAN; INTERNAL MEDICINE; LIVER CELL CARCINOMA; LIVER DISEASE; MEDICAL RESEARCH; PANCREAS CARCINOMA; PANCREATITIS; SCREENING; STOMACH; SURGERY; ULCERATIVE COLITIS;

FORECASTING; GASTROENTEROLOGY; GASTROINTESTINAL DISEASES; HUMANS; INTERNAL MEDICINE; PATIENT CARE TEAM; QUALITY ASSURANCE, HEALTH CARE;

EID: 0031958041     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080050185     Document Type: Article

References (41)

1. Goodwin C, Mendall M, Northfield C (1997) Helicobacter pylori infection. Lancet 349:265-269
2. Malfertheiner P et al (1997) Current European concepts in the management of helicobacter pylori infection. Gut 41:8-13
3. Endo S, Okhusa T, Saito Y, Fujiki K, Okayasu I, Sato C (1995) Detection of helicobacter pylori infection in early stage gastric cancer. A comparison between intestinal-and diffuse-type gastric adenocarcinomas. Cancer 75:2203-2208
4. Mussel T, Isaacson PG, Crabtree JE, Spencer J (1996) Helicobacter pylori specific tumorinfiltrating T-cells provide contact dependent help for the growth of malignant B-cells in low-grade gastric MALT-lymphoma of mucosa-associated lymphoid tissue. J Pathol 178:122-127
5. Neubauer A, Thiede C, Alpen A, Morgner A, Rudolph B, Seifert E, Huhn D, Bayerdörfer E, Stolte M (1997) Biologie und Klinik der MALT-Lymphome. In: Höffkes HG, Uppenkamp M (Hrsg) Maligne Lymphome. Springer, Berlin Heidelberg, S 65-73
6. Corthesy-Theulaz I, Porta N, Glauser M, Saraga E, Vaney AC, Haas R, Kraehenbuhl JP, Blum AL, Michetti P (1995) Oral immunization with helicobacter pylori urease B subunit as a treatment against helicobacter infection in mice. Gastroenterology 109:115-121
7. Michetti P (1997) Vaccine against helicobacter pylori: fact or fiction? Gut 41:728-730
8. Hugot JP, Laurent-Puig P, Gower-Rousseau C et al (1996) Mapping of susceptibility locus for Crohn's disease on Chromosom 16. Nature 379:821-823
9. Satsangi J, Parkes M, Louis E et al (1996) Two-stage genome-wide search in inflammatory bowel diseases provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nature Genetics 14:199-202
10. Schreiber S, Heinig T, Thiele HG, Raedler A (1995) Immunoregulatory role of Interleukin 10 in patients with inflammatory bowel disease. Gastroenterologey 108:1434-1444
11. Schreiber S, Nikolaus S, Hampe J (1998) Activation of nuclear factor kappa B in inflammatory bowel disease. Gut (im Druck)
12. Targan SR, Hanauer SB, van Deventer SJH et al (1997) A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. New Engl J Med 337:1029-1035
13. Irvine EJ, Feagan B, Rochon J et al (1994) Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology 106:287-294
14. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorgenesis. Cell 61:759-767
15. Vogelstein B, Fearon ER, Kern SE (1989) Allelotype of colorectal carcinomas. Science 244:207-213
16. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, van TP, Ledbetter DH, Barker DF, Nakamura Y et al (1989) Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244:217-221
17. Levine AJ (1997) p53, the cellular gate-keeper for growth and divison. Cell 88:323-331
18. Winawer SJ, Fletcher RH, Miller L et al (1997) Colorectal cancer screening: Clinical guidelines and rationale gastroenterology. 112:594-642
19. Eddy DM, Nugent FW, Eddy JF et al (1987) Screening for colorectal cancer in a high-risk population: results of a mathematical model. Gastroenterology 92:682-692
20. Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch JF, Lynch PM, Cavalieri RJ, Boland CR (1993) Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104:1535-1549
21. Whitcomb D, Preston RA, Aston CE et al (1996) A gene for hereditary pancreatitis maps to chromosome 7 q35. Gastroenterology 110:1975-1980
22. Kingsnorth AN, Galloway SW, Formela LJ (1995) Randomised, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis. Br J Surg 82:1414-1420
23. Menke A, Yamaguchi H, Gress TM, Adler G (1997) Extracellular matrix is reduced by inhibition of transforming growth factor beta 1 in pancreatitis in the rat. Gastroenterology 113:295-303
24. Sanvito F, Nichols A, Herrera PL et al (1995) TGF-beta 1 overexpression in murine pancreas induces chronic pancreatitis and, together with TNF-alpha, triggers insulin-dependent diabetes. Biochem Biophys Res Commun 217:1279-1286
25. Kerem E, Rammens J, Buchanan JA et al (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073-1080
26. Hahn SA, Schutte M, Hoque AT (1989) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350-354
27. Chisari FV, Ferrari C (1995) Hepatitis B virus immunepathogenesis. Ann Rev Immunol 13:29-60
28. Manns MP, Johnson EF, Griffin KJ, Tan EM, Sullivan KF (1989) Major antigen of liver microsomal antibodies in idiopathic autoimmune hepatitis is cytochrome P45db1. J Clin Invest 83:1066-1077
29. Coppel RL, McNeilage LJ, Surh CD, van de Water J, Spithill TW, Whittingham S, Gershwin ME (1988) Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide actyltransferase. Proc Natl Acad Sci 85:7317-7321
30. Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW (1995) The Wilson's disease gene: spectrum of mutations and their consequences. Nature Genetics 9:210-217
31. Feder JN, Gnirke A, Thomas W et al. (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics 13:399-408
32. Lutwick LI (1979) Relation between aflatoxins and hepatitis B virus and heptatocullular carcinoma. Lancet 755-759
33. Beasly RP, Hwang LY, Lin CC (1981) Hepatocullular carcinoma and hepatitis B virus: a prospective study of 22707 men in Taiwan. Lancet 2:1129-1132
34. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel E, Krammer PH, Runkel L (1995) Involvement on the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 182:1223-1230
35. Kohler B, Maier M, Benz C et al. (1997) Acute ulcer bleeding. A prospective randomized trial to compare Doppler and Forrest classifications in endoscopic diagnosis and therapy. Dig Dis Sci 42:1370-1374
36. Soto JA, Barish MA, Yucel EK et al (1995) MR cholangiopancreatography: findings on 3D fast spin-echo imaging. AJR 165:1397-1401
37. Rösch T (1993) Endosonographie des Gastrointestinaltrakts - eine Bestandsaufnahme. Bildgebung 60:169-175
38. Donabedian A (1966) Evaluating the quality of medical care. Millbank Mem Fund Q 44:166-206
39. Sauerbruch T, Scheurlen Ch (Hrsg) (1997) Leitlinien der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS). 2 Aufl, Demeter, Balingen
40. Riemann JF, Manns MP (1995) Vorschlag der Deutschen Gesellschaft für Verdauungs-und Stoffwechselkrankheiten (DGVS) für die Fachkunde Koloskopie. Z Gastroenterol 33:577
41. Riemann JF, Birkner B, Hahn EG (1996) Qualitätsbeurteilung in der Endoskopie. Internist 37:830-838